Grants and Contributions

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

Scale and Spread of Successful Existing CBPHC and eHealth Innovations grant is expected to:
• Support the adoption of successful CBPHC and eHealth innovations to new sites, new settings, or new populations.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

• This prize was established to recognize the excellence of cancer research being conducted in Canada. This prize will be given annually to Early Career Investigators ranking high in the Project Scheme competitions that fall within the Institute of Cancer Research (ICR) mandate:

o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

Scale and Spread of Successful Existing CBPHC and eHealth Innovations grant is expected to:
• Support the adoption of successful CBPHC and eHealth innovations to new sites, new settings, or new populations.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

The Understanding Disease Prevention and Risk Factor Modification Catalyst Grants are expected to:

• increase our understanding of factors that enable individuals to adopt or overlook known disease risk modification strategies;
• expand the evidence and further understanding that can lead to future intervention studies in prevention; and
• develop a knowledge base upon which to nuance evidence-based policy to improve the prevention of manageable diseases.

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

The Understanding Disease Prevention and Risk Factor Modification Catalyst Grants are expected to:

• increase our understanding of factors that enable individuals to adopt or overlook known disease risk modification strategies;
• expand the evidence and further understanding that can lead to future intervention studies in prevention; and
• develop a knowledge base upon which to nuance evidence-based policy to improve the prevention of manageable diseases.

The funding opportunity Catalyst Grant: HIV/AIDS Community-Based Research is expected to:
•Support partnerships between communities affected by HIV and other STBBI in Canada and researchers to facilitate the conduct of CBR; and/or
•Develop future applications for more comprehensive CBR grants in the area of HIV and other STBBI in Canada.

Examples of activities that might be conducted under this request for applications are (but are not restricted to):
•Facilitation of dialogue between communities and researchers in order to establish research partnerships;
•Workshops to design a research project and/or develop a proposal for a future CBR operating grant;
•Planning and execution of pilot projects or feasibility studies to generate preliminary data, proof of concept; and/or
•Development and/or validation of new interventions, tools, methodologies, protocols, theoretical models or frameworks.

For examples, applicants can visit CIHR's Funding Decisions web site to search for projects previously funded under a CIHR HIV/AIDS CBR Catalyst Grant.

• The Institute of Neurosciences, Mental Health and Addiction (INMHA) will fund an application that is determined to be relevant to the mandate and research priority areas of CIHR-INMHA
o The Institute of Neurosciences, Mental Health and Addiction supports (INMHA) research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.